Market News
Global Plant-based Vaccines Market: Key Developments
- On September 24, 2020, Lumen Bioscience, Inc., a pharmaceutical company, received US$ 4 million grant from Series B financing round from the investors such as WestRiver Management, Bioeconomy Capital, and others. The company is planning to use the funding for engineering the spirulina for the production of COVID-19 vaccine.
- In June 2022, Mazen Animal Health, a biotechnology company, announced that the company is getting closer to completing the development of a novel vaccine that would be produced in corn and administered through animal feed.